Pharmacology
 |
|
19 march 2019 18:03:56 |
| The future of pharmacogenetics in the treatment of hypertension (Pharmacogenomics) |
|
Tweet Pharmacogenomics, Volume 20, Issue 3, Page 129-132, February 2019. |
| 45 viewsCategory: Genomics, Pharmacology |
 Correction: Polymorphisms at phase I-metabolizing enzyme and
hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis
patients (Pharmacogenomics Journal)Association of endothelin receptor type A rs5333 gene polymorphism with steroid response in Egyptian children with idiopathic nephrotic syndrome (Pharmacogenomics) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
